智通财经APP讯，福元医药(601089.SH)发布公告，近日，公司收到了国家药品监督管理局(简称“国家药监局”)核准签发的酮洛芬贴剂的《药物临床试验批准通知书》。
该药品申请适应症：①以下疾病和症状的镇痛、消炎：腰痛(肌肉或筋膜性腰痛、变形性脊椎病、椎间盘疾病、腰椎挫伤)、骨关节炎、肩周炎、肌腱及腱鞘炎、肌腱周围炎、肱骨外上髁炎(网球肘等)、肌肉痛、创伤后肿胀疼痛。②类风湿性关节炎的关节局部镇痛。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.